Journal article

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.

J Grebely, K Petoumenos, GV Matthews, P Haber, P Marks, AR Lloyd, JM Kaldor, GJ Dore, M Hellard, undefined ATAHC Study Group

Drug and Alcohol Dependence | Published : 2010


Despite that the majority of hepatitis C virus (HCV) infection occurs among injection drug users (IDUs), little is known about HCV treatment uptake in this group, particularly during recent infection. We evaluated uptake of treatment for recent HCV infection, including associated factors, within a population predominantly made up of IDUs. The Australian Trial in Acute Hepatitis C was a study of the natural history and treatment of recent HCV infection. All participants with detectable HCV RNA at screening were offered HCV treatment, assessed for eligibility and those initiating treatment were identified. Logistic regression analyses were used to identify predictors of HCV treatment uptake. B..

View full abstract

University of Melbourne Researchers